Association of LI-RADS and Histopathologic Features with Survival in Patients with Solitary Resected Hepatocellular Carcinoma

医学 肝细胞癌 危险系数 比例危险模型 倾向得分匹配 回顾性队列研究 磁共振成像 生存分析 置信区间 放射科 胃肠病学 内科学
作者
Roberto Cannella,Francesco Matteini,Marco Dioguardi Burgio,Riccardo Sartoris,Aurélie Beaufrère,Julien Caldéraro,Sebastien Mulé,Édouard Reizine,Alain Luciani,Alexis Laurent,Olivier Séror,Nathalie Ganne‐Carriè,Mathilde Wagner,Olivier Scatton,Valérie Vilgrain,François Cauchy,Christian Hobeika,Maxime Ronot
出处
期刊:Radiology [Radiological Society of North America]
卷期号:310 (2): e231160-e231160 被引量:16
标识
DOI:10.1148/radiol.231160
摘要

Background Both Liver Imaging Reporting and Data System (LI-RADS) and histopathologic features provide prognostic information in patients with hepatocellular carcinoma (HCC), but whether LI-RADS is independently associated with survival is uncertain. Purpose To assess the association of LI-RADS categories and features with survival outcomes in patients with solitary resected HCC. Materials and Methods This retrospective study included patients with solitary resected HCC from three institutions examined with preoperative contrast-enhanced CT and/or MRI between January 2008 and December 2019. Three independent readers evaluated the LI-RADS version 2018 categories and features. Histopathologic features including World Health Organization tumor grade, microvascular and macrovascular invasion, satellite nodules, and tumor capsule were recorded. Overall survival and disease-free survival were assessed with Cox regression models. Marginal effects of nontargetoid features on survival were estimated using propensity score matching. Results A total of 360 patients (median age, 64 years [IQR, 56-70 years]; 280 male patients) were included. At CT and MRI, the LI-RADS LR-M category was associated with increased risk of recurrence (CT: hazard ratio [HR] = 1.83 [95% CI: 1.26, 2.66], P = .001; MRI: HR = 2.22 [95% CI: 1.56, 3.16], P < .001) and death (CT: HR = 2.47 [95% CI: 1.72, 3.55], P < .001; MRI: HR = 1.80 [95% CI: 1.32, 2.46], P < .001) independently of histopathologic features. The presence of at least one nontargetoid feature was associated with an increased risk of recurrence (CT: HR = 1.80 [95% CI: 1.36, 2.38], P < .001; MRI: HR = 1.93 [95% CI: 1.81, 2.06], P < .001) and death (CT: HR = 1.51 [95% CI: 1.10, 2.07], P < .010) independently of histopathologic features. In matched samples, recurrence was associated with the presence of at least one nontargetoid feature at CT (HR = 2.06 [95% CI: 1.15, 3.66]; P = .02) or MRI (HR = 1.79 [95% CI: 1.01, 3.20]; P = .048). Conclusion In patients with solitary resected HCC, LR-M category and nontargetoid features were negatively associated with survival independently of histopathologic characteristics. © RSNA, 2024 Supplemental material is available for this article. See also the editorial by Kartalis and Grigoriadis in this issue.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
清新的纹发布了新的文献求助10
1秒前
mmmmm的应助被Lik采纳,获得10
2秒前
gm完成签到,获得积分10
2秒前
潇洒的巧凡完成签到 ,获得积分10
3秒前
让我想想完成签到,获得积分10
5秒前
5秒前
5秒前
6秒前
香蕉觅云的应助被往往小陈采纳,获得10
7秒前
拼搏向上发布了新的文献求助30
8秒前
wc完成签到,获得积分10
9秒前
ycy发布了新的文献求助10
9秒前
王义博完成签到,获得积分10
9秒前
顾矜的应助被Joshua采纳,获得10
9秒前
sswww发布了新的文献求助10
11秒前
12秒前
斯文败类的应助被王思聪采纳,获得10
12秒前
Cathy完成签到,获得积分10
12秒前
15秒前
15秒前
16秒前
李健的应助被dmy采纳,获得10
17秒前
科研通AI6.4的应助被cvvfdfd采纳,获得10
18秒前
zyyyyyy发布了新的文献求助10
19秒前
20秒前
可爱的函函的应助被勇敢聪聪采纳,获得10
21秒前
21秒前
mmmmm的应助被清新的苑博采纳,获得10
21秒前
sapphire完成签到,获得积分10
21秒前
21秒前
简单无极发布了新的文献求助10
22秒前
Owen的应助被欣喜战斗机采纳,获得10
22秒前
Deliaaaly关注了科研通微信公众号
22秒前
24秒前
Joshua发布了新的文献求助10
24秒前
24秒前
25秒前
CodeCraft的应助被简单无极采纳,获得10
26秒前
opp完成签到,获得积分10
26秒前
27秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Rosenblum, Global Change Biology 800
自動車の空力技術 800
Organizational Behavior 510
Management and the Arts 510
Issues in Task-Based Language Teaching 500
Geschichtliche Grundbegriffe (GGB), Band 5: Pro–Soz 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 化学工程 工程类 有机化学 物理 复合材料 生物化学 内科学 细胞生物学 基因 遗传学 免疫学 冶金 光电子学 癌症研究
热门帖子
关注 科研通微信公众号,转发送积分 7787690
求助须知:如何正确求助?哪些是违规求助? 9326068
关于积分的说明 20408774
捐赠科研通 7376531
什么是DOI,文献DOI怎么找? 3322314
关于科研通互助平台的介绍 2469998
邀请新用户注册赠送积分活动 2338852